<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37229071</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2049-0801</ISSN><JournalIssue CitedMedium="Print"><Volume>85</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Annals of medicine and surgery (2012)</Title><ISOAbbreviation>Ann Med Surg (Lond)</ISOAbbreviation></Journal><ArticleTitle>Prevalence and difference of COVID-19 symptoms, post-COVID conditions and duration of illness among the vaccinated and unvaccinated population: a cross-sectional study in Peshawar.</ArticleTitle><Pagination><StartPage>1678</StartPage><EndPage>1684</EndPage><MedlinePgn>1678-1684</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MS9.0000000000000606</ELocationID><Abstract><AbstractText Label="UNLABELLED">Studies on coronavirus disease 2019 (COVID-19) symptoms, post-coronavirus disease (COVID) conditions, and vaccination outcomes in Pakistan are limited and inconsistent. The study investigated differences in symptoms and post-COVID conditions between vaccinated and unvaccinated individuals and the impact of vaccination on illness duration based on existing literature.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The study was a 3-month cross-sectional study conducted in Peshawar, Pakistan. It targeted individuals aged 16 and above who had contracted COVID-19 at least once during the recent pandemic, regardless of gender, and confirmed through reverse transcriptase polymerase chain reaction testing. The sample size was 250, determined using the WHO sample size calculator. Data were collected through questionnaires after obtaining verbal consent and analyzed using IBM SPSS version 26, taking into account their vaccination status along with other important variables.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among the 250 respondents, 143 (57.2%) were unvaccinated, while 107 (42.8%) were vaccinated at the time of contracting COVID-19. Unvaccinated subjects developed a greater variety of symptoms that lasted for longer durations (<i>P</i>&lt;0.001) with symptoms like dyspnea [55 (38.5%, <i>P</i>=0.011)], anosmia [76 (53.1%, <i>P</i>=0.001)], and chest pain [24 (16.8%, <i>P</i>=0.029)] occurring at greater percentages. Sixty-one (42.7%) unvaccinated subjects reported post-COVID conditions as opposed to 29 (27.1%) among the vaccinated group [<i>P</i>=0.011; odds ratio (OR)=0.5; 95% CI=0.29-0.86].</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The study found that COVID-19 vaccination can reduce the duration and frequency of symptoms, as well as post-COVID conditions. This is the first research of its kind conducted in Peshawar, Pakistan, and may serve as a foundation for future research in this demographic.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rahman</LastName><ForeName>Asad</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0534-6292</Identifier><AffiliationInfo><Affiliation>Departments of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikram</LastName><ForeName>Muhammad T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Departments of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arif</LastName><ForeName>Amina</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8613-2148</Identifier><AffiliationInfo><Affiliation>Departments of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Bakht D</ForeName><Initials>BD</Initials><Identifier Source="ORCID">0000-0001-9661-4389</Identifier><AffiliationInfo><Affiliation>Ophthalmology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azam</LastName><ForeName>Kamal U</ForeName><Initials>KU</Initials><Identifier Source="ORCID">0000-0001-5643-376X</Identifier><AffiliationInfo><Affiliation>Departments of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fida</LastName><ForeName>Muhammad Sanaan</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0001-6294-5307</Identifier><AffiliationInfo><Affiliation>Khyber Medical College, Peshawar, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahim</LastName><ForeName>Adam K</ForeName><Initials>AK</Initials><Identifier Source="ORCID">0000-0003-4957-3419</Identifier><AffiliationInfo><Affiliation>Departments of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Muhammad S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0002-1230-8120</Identifier><AffiliationInfo><Affiliation>Khyber Medical College, Peshawar, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mushtaq</LastName><ForeName>Muhammad H</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0000-0003-2425-7196</Identifier><AffiliationInfo><Affiliation>Khyber Medical College, Peshawar, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fida</LastName><ForeName>Raiyan</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-4155-0928</Identifier><AffiliationInfo><Affiliation>Khyber Medical College, Peshawar, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yunus</LastName><ForeName>Hamza</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-2034-7314</Identifier><AffiliationInfo><Affiliation>Departments of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Mohammad D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Surgery, Hayatabad Medical Complex.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Med Surg (Lond)</MedlineTA><NlmUniqueID>101616869</NlmUniqueID><ISSNLinking>2049-0801</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">outbreak and pandemic</Keyword><Keyword MajorTopicYN="N">post-COVID conditions</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList><CoiStatement>The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>25</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>25</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>25</Day><Hour>14</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37229071</ArticleId><ArticleId IdType="pmc">PMC10205198</ArticleId><ArticleId IdType="doi">10.1097/MS9.0000000000000606</ArticleId><ArticleId IdType="pii">AMSU-D-22-02962</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol 2020;92:401&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166628</ArticleId><ArticleId IdType="pubmed">31950516</ArticleId></ArticleIdList></Reference><Reference><Citation>Coopersmith CM, Antonelli M, Bauer SR, et al. . The surviving sepsis campaign: research priorities for coronavirus disease 2019 in critical illness. Crit Care Med 2021;49:598&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pubmed">33591008</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinosa PS, Rizvi Z, Sharma P, et al. . Neurological complications of coronavirus disease (COVID-19): encephalopathy, MRI brain and cerebrospinal fluid findings: case 2. Cureus 2020;12:e7930.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7266087</ArticleId><ArticleId IdType="pubmed">32499974</ArticleId></ArticleIdList></Reference><Reference><Citation>Filatov A, Sharma P, Hindi F, et al. . Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus 2020;12:e7352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7170017</ArticleId><ArticleId IdType="pubmed">32328364</ArticleId></ArticleIdList></Reference><Reference><Citation>Long B, Brady WJ, Koyfman A, et al. . Cardiovascular complications in COVID-19. Am J Emerg Med 2020;38:1504&#x2013;1507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7165109</ArticleId><ArticleId IdType="pubmed">32317203</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Marks F, Clemens JD. Looking beyond COVID-19 vaccine phase 3 trials. Nat Med 2021;27:205&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">33469205</ArticleId></ArticleIdList></Reference><Reference><Citation>Polack FP, Thomas SJ, Kitchin N, et al. . Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020;31:2603&#x2013;2615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Waheed S, Bayas A, Hindi F, et al. . Neurological complications of COVID-19: Guillain&#x2013;Barr&#xe9; syndrome following Pfizer COVID-19 vaccine. Cureus 2021;13:e13426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7978140</ArticleId><ArticleId IdType="pubmed">33758714</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabaan AA, Bakhrebah MA, Mutair AA, et al. . Systematic review on pathophysiological complications in severe COVID-19 among the non-vaccinated and vaccinated population. Vaccines (Basel) 2022;10:985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9318201</ArticleId><ArticleId IdType="pubmed">35891149</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyanka COP, Singh I, Patra G. Aerosol transmission of SARS-CoV-2: the unresolved paradox. Travel Med Infect Dis 2020;37:101869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471761</ArticleId><ArticleId IdType="pubmed">32891726</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA 2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew G, Agha R, Albrecht J, et al. . STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case&#x2013;control studies in surgery. Int J Surg 2021;96:106165.</Citation><ArticleIdList><ArticleId IdType="pubmed">34774726</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatima S, Zafar A, Afzal H, et al. . COVID-19 infection among vaccinated and unvaccinated: does it make any difference? PLoS One 2022;17:e0270485.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9286242</ArticleId><ArticleId IdType="pubmed">35839210</ArticleId></ArticleIdList></Reference><Reference><Citation>Gul W, Samin KA, Ahmad R, et al. . Comparison of severity of symptoms and outcome among vaccinated and non-vaccinated covid 19 patients in Khyber Pakhtunkhwa, Pakistan. Pak J Med Health Sci 2021;15:2334&#x2013;2337.</Citation></Reference><Reference><Citation>Khan JA, Satti L, Bizanjo M, et al. . Comparison of clinical characteristics and outcome between vaccinated and non-vaccinated patients of Covid-19 during the Delta variant-dominated fourth wave in a tertiary care hospital in Karachi, Pakistan. Cureus 2022;14:e23726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9060754</ArticleId><ArticleId IdType="pubmed">35509752</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. . Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case&#x2013;control study. Lancet Infect Dis 2022;22:43&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Korishettar G, Chikkahonnaiah P, Tulimilli SV, et al. . Assessment of Clinical Profile and Treatment Outcome in Vaccinated and Unvaccinated SARS-CoV-2 Infected Patients. Vaccines (Basel). 2022;10:1125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9321523</ArticleId><ArticleId IdType="pubmed">35891289</ArticleId></ArticleIdList></Reference><Reference><Citation>
COVID.gov. Long COVID | COVID-19 Treatment Guidelines. National Institutes of Health, U.S. Department of Health and Human Services, 2021.
https://www.covid.gov/longcovid/definitions
</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun 2022;103:154&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon MA, Luginbuhl RD, Parker R. Reduced incidence of long-COVID symptoms related to administration of COVID-19 vaccines both before COVID-19 diagnosis and up to 12 weeks after. medRxiv 2021. 10.1101/2021.11.17.21263608</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.17.21263608</ArticleId></ArticleIdList></Reference><Reference><Citation>
Tran V-T Perrodeau E Saldanha J, et al. . Efficacy of COVID-19 vaccination on the symptoms of patients with long COVID: a target trial emulation using data from the ComPaRe e-cohort in France. SSRN, 2021.
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3932953
</Citation></Reference><Reference><Citation>Nehme M, Braillard O, Salamun J, et al. . Symptoms after COVID-19 vaccination in patients with post-acute sequelae of SARS-CoV-2. J Gen Intern Med 2022;37:1585&#x2013;1588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8863092</ArticleId><ArticleId IdType="pubmed">35194744</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, et al. . Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ 2022;377:e069676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisnivesky JP, Govindarajulu U, Bagiella E, et al. . Association of vaccination with the persistence of post-COVID symptoms. J Gen Intern Med 2022;37:1748&#x2013;1753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8906626</ArticleId><ArticleId IdType="pubmed">35266128</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. Covid-19: vaccinated people are less likely to get long covid, review finds. BMJ 2022;376:o407.</Citation><ArticleIdList><ArticleId IdType="pubmed">35172970</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID [published correction appears in Nat Med. 2021;27(6):1116]. Nat Med 2021;27:626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K, et al. . Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One 2020;15:e0240784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>